NATH BIOGENES (INDIA)
Back to Balance Sheet
|
NATH BIOGENES (INDIA) Last 5 Year Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Current Liabilities | - | - | - | - | - |
What is the latest Current Liabilities ratio of NATH BIOGENES (INDIA) ?
| Year | Current Liabilities |
|---|---|
| Mar2026 | - |
| Mar2025 | - |
| Mar2024 | - |
| Mar2023 | - |
| Mar2022 | - |
How is Current Liabilities of NATH BIOGENES (INDIA) Trending?
| Years | Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | - | 0 | |
| Mar2025 | - | 0 | |
| Mar2024 | - | 0 | |
| Mar2023 | - | 0 | |
| Mar2022 | - | - | |
Compare Current Liabilities of peers of NATH BIOGENES (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATH BIOGENES (INDIA) | ₹275.1 Cr | -1.7% | -5.4% | -9.8% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹3,975.2 Cr | 10.4% | -1.5% | -30.1% | Stock Analytics | |
| VENKYS (INDIA) | ₹2,297.7 Cr | -2.5% | 3.5% | 9.7% | Stock Analytics | |
| AVT NATURAL PRODUCTS | ₹1,320.5 Cr | -11.8% | 1.1% | 25.1% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹900.2 Cr | 2% | -5.1% | NA | Stock Analytics | |
| MANGALAM GLOBAL ENTERPRISE | ₹524.3 Cr | 2.6% | 9% | 0.7% | Stock Analytics | |
NATH BIOGENES (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATH BIOGENES (INDIA) | -1.7% |
-5.4% |
-9.8% |
| SENSEX | -2.8% |
-6.1% |
-11.9% |
You may also like the below Video Courses